Cargando…

Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets

Corynebacterium pseudotuberculosis is an important animal pathogen, which is also able to infect humans. An optimal treatment of infections with this pathogen is not available today and consequently, more research is necessary to understand the infection process. Here, we present a combined -omics a...

Descripción completa

Detalles Bibliográficos
Autores principales: Möller, Jens, Bodenschatz, Mona, Sangal, Vartul, Hofmann, Jörg, Burkovski, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784263/
https://www.ncbi.nlm.nih.gov/pubmed/36548458
http://dx.doi.org/10.3390/proteomes10040039
_version_ 1784857768679702528
author Möller, Jens
Bodenschatz, Mona
Sangal, Vartul
Hofmann, Jörg
Burkovski, Andreas
author_facet Möller, Jens
Bodenschatz, Mona
Sangal, Vartul
Hofmann, Jörg
Burkovski, Andreas
author_sort Möller, Jens
collection PubMed
description Corynebacterium pseudotuberculosis is an important animal pathogen, which is also able to infect humans. An optimal treatment of infections with this pathogen is not available today and consequently, more research is necessary to understand the infection process. Here, we present a combined -omics and bioinformatics approach to characterize C. pseudotuberculosis 12CS0282. The genome sequence of strain 12CS0282 was determined, analyzed in comparison with the available 130 C. pseudotuberculosis sequences and used as a basis for proteome analyses. In a reverse vaccinology approach, putative vaccine and drug targets for 12CS0208 were identified. Mass spectrometry analyses revealed the presence of multiple virulence factors even without host contact. In macrophage interaction studies, C. pseudotuberculosis 12CS0282 was highly resistant against human phagocytes and even multiplied within human THP-1 cells. Taken together, the data indicate a high pathogenic potential of the strain.
format Online
Article
Text
id pubmed-9784263
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97842632022-12-24 Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets Möller, Jens Bodenschatz, Mona Sangal, Vartul Hofmann, Jörg Burkovski, Andreas Proteomes Article Corynebacterium pseudotuberculosis is an important animal pathogen, which is also able to infect humans. An optimal treatment of infections with this pathogen is not available today and consequently, more research is necessary to understand the infection process. Here, we present a combined -omics and bioinformatics approach to characterize C. pseudotuberculosis 12CS0282. The genome sequence of strain 12CS0282 was determined, analyzed in comparison with the available 130 C. pseudotuberculosis sequences and used as a basis for proteome analyses. In a reverse vaccinology approach, putative vaccine and drug targets for 12CS0208 were identified. Mass spectrometry analyses revealed the presence of multiple virulence factors even without host contact. In macrophage interaction studies, C. pseudotuberculosis 12CS0282 was highly resistant against human phagocytes and even multiplied within human THP-1 cells. Taken together, the data indicate a high pathogenic potential of the strain. MDPI 2022-11-23 /pmc/articles/PMC9784263/ /pubmed/36548458 http://dx.doi.org/10.3390/proteomes10040039 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Möller, Jens
Bodenschatz, Mona
Sangal, Vartul
Hofmann, Jörg
Burkovski, Andreas
Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets
title Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets
title_full Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets
title_fullStr Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets
title_full_unstemmed Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets
title_short Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets
title_sort multi-omics of corynebacterium pseudotuberculosis 12cs0282 and an in silico reverse vaccinology approach reveal novel vaccine and drug targets
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784263/
https://www.ncbi.nlm.nih.gov/pubmed/36548458
http://dx.doi.org/10.3390/proteomes10040039
work_keys_str_mv AT mollerjens multiomicsofcorynebacteriumpseudotuberculosis12cs0282andaninsilicoreversevaccinologyapproachrevealnovelvaccineanddrugtargets
AT bodenschatzmona multiomicsofcorynebacteriumpseudotuberculosis12cs0282andaninsilicoreversevaccinologyapproachrevealnovelvaccineanddrugtargets
AT sangalvartul multiomicsofcorynebacteriumpseudotuberculosis12cs0282andaninsilicoreversevaccinologyapproachrevealnovelvaccineanddrugtargets
AT hofmannjorg multiomicsofcorynebacteriumpseudotuberculosis12cs0282andaninsilicoreversevaccinologyapproachrevealnovelvaccineanddrugtargets
AT burkovskiandreas multiomicsofcorynebacteriumpseudotuberculosis12cs0282andaninsilicoreversevaccinologyapproachrevealnovelvaccineanddrugtargets